Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Effects of Acoramidis on Kidney Function in Transthyretin Amyloid Cardiomyopathy.
Journal: Circulation. Heart failure
Published: July 02, 2026
PTH-Independent CaSR Inhibition with the Oral Calcilytic Encaleret Improves Calcium Homeostasis in Post-Surgical Hypoparathyroidism: A Phase 2 Open-Label Proof-of-Concept Trial.
Journal: Research square
Published: May 25, 2026
PTH-Independent CaSR Inhibition with the Oral Calcilytic Encaleret Improves Calcium Homeostasis in Post-Surgical Hypoparathyroidism: A Phase 2 Open-Label Proof-of-Concept Trial.
Journal: Research square
Published: May 25, 2026
A calcium-sensing receptor allelic series and underdiagnosis of genetically driven hypocalcemia.
Journal: American journal of human genetics
Published: November 19, 2024
Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury.
Journal: Clinical pharmacology and therapeutics
Published: August 16, 2024
Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design.
Journal: Trials
Published: December 10, 2021
Anti-interleukin-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism.
Journal: Transplant international : official journal of the European Society for Organ Transplantation
Published: April 10, 2021
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: October 24, 2018
Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.
Journal: Rheumatology (Oxford, England)
Published: January 11, 2017
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 14, 2016
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).
Journal: Annals of the rheumatic diseases
Published: January 17, 2016
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 06, 2016
Last Updated: 09/26/2026